El Grup Català de Citogenètica en lluita per l’Especialitat de genètica #EspecialitatJA Hospital del Mar

Hoy estoy asistiendo a la "Diada hematològica”, dedicado a profundizar en las neoplasias hematológicas con predisposición genética 🧬🔬 Un placer compartir conocimientos con expertos en el campo #NHPG

📢Maria Gabarros, de Hematologia - Hospital Universitari Vall d'Hebron, presenta los datos de su estudio sobre la inestabilidad genómica en pacientes con mutaciones germinales en genes de la via NHEJ🧬🩸 Datos del gesmd ¡ENHORABONA! #Hemato2024 @sehh_es

🎯Pasad por el stand de GSK! Os espera La Familia #hemato2024 Maria Jose Calasanz 🔝

Hoy presenté nuestro trabajo en el Congreso #SEHH: desafíos diagnósticos en un laboratorio de rutina para la LLA-B 🔬. Las nuevas técnicas ayudan, pero cariotipo y FISH siguen siendo clave 💪✨ #Citogenética #Hemato2024 Hematologia - Hospital Universitari Vall d'Hebron

ACTUALIDAD | Un logro histórico: Se acaba dar el visto bueno de la Comisión de RRHH del SNS a las especialidades de Genética Médica y Genética de Laboratorio Una lucha durante 50 años de la Asociación Española de Genética Humana (AEGH) que hoy se ve cumplida. aegh.org/la-aegh-consid…

Here we are!!! #ASH24 My first time attending ASH, very exited (and nervous for my presentation today 🫣)

Ximena Jordan Bruno @sehh_es María Díez Campelo Thanks Ximena! A dedicated unit with Sara & @montoro_julia showing the way. Everything written here (in spanish) by almost 100 “germline” authors😊 sehh.es/images/stories…

First time attending the annual ASH meeting in San Diego! Excited to be part of such an important event in the field of hematology. Ready to learn, share, and connect with colleagues from around the world! #ASH24 #Hematology

Insightful talk at #ASH24 by Ashley Pinchinat on t(1;19) in pediatric B-ALL. Cytogenetics, particularly t(1;19), is key for stratification, with improved DFS and OS compared to other neutral cytogenetics. Cytogenetics is crucial! 🧬#Hematology #PediatricALL

Amazing talk at #ASH24 by Alina M. Hartmann on KMT2A-rearranged BCP-ALL. Immaturity and fusion partner could predict drug response and outcomes better than age. #Hematology #ALL

Excellent talk at #ASH24 by @mgabarros on donor cell-derived hematologic neoplasms. Pathogenic germline variants in the donor are a significant factor in DCHN development. Very proud of you, my friend! ✨ #Hematology #DCHN

In this Spanish cohort (n=10) of patients with donor-cell derived hematologic malignacies, 6 were found due to germline mutations in the related donors, another important message to always screen for #germline predisposition prior to HSCT #ASH24 #ASHKudos @mgabarros

Proud to present our research at #ASH24! A great opportunity to share our findings and engage with the hematology community #Hematology #ASH2024

How to combine multiple tools for the genetic diagnosis work-up of pediatric B-cell #AcuteLymphoblasticLeukemia: link.springer.com/article/10.100…